HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Class Action Claims Often Follow Regulatory Action, Industry Litigation

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA warning letters, FTC consent orders, Lanham Act litigation and National Advertising Division reviews all provide fodder for attorneys looking to bring consumer product lawsuits. While some case settlements come with large monetary payments, injunctive components also are common and often costly.

You may also be interested in...



Dannon's FTC Settlement Requires FDA Approval For Cold/Flu Immunity Claims

The Dannon Co. will drop "exaggerated" health claims for two yogurt products, including claims in advertising with actress Jamie Lee Curtis, under a settlement with the Federal Trade Commission.

FDA Warning Letter To Coke Could Mean Trouble For Health Drink Market

An FDA warning letter to Coca-Cola states Diet Coke Plus is misbranded in part because it is inappropriate to fortify carbonated beverages

Mead Johnson Enfamil Ads Withdrawn After Restraining Order

Mead Johnson distributed roughly 90,000 letters in late April informing pediatricians its previously circulated literature regarding store-brand infant formulas contained incorrect information about calcium and folic acid levels.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS125023

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel